These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3165982)

  • 1. Treatment and prevention of basal cell carcinoma with oral isotretinoin.
    Peck GL; DiGiovanna JJ; Sarnoff DS; Gross EG; Butkus D; Olsen TG; Yoder FW
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):176-85. PubMed ID: 3165982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention of basal cell carcinoma with isotretinoin.
    Peck GL; Gross EG; Butkus D; DiGiovanna JJ
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):815-23. PubMed ID: 6950957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term retinoid therapy is needed for maintenance of cancer chemopreventive effect.
    Peck GL
    Dermatologica; 1987; 175 Suppl 1():138-44. PubMed ID: 3480250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical tretinoin in actinic keratosis and basal cell carcinoma.
    Peck GL
    J Am Acad Dermatol; 1986 Oct; 15(4 Pt 2):829-35. PubMed ID: 3534022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of skin cancer in xeroderma pigmentosum with oral isotretinoin.
    Moshell AN
    Cutis; 1989 May; 43(5):485-90. PubMed ID: 2721244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin.
    Kraemer KH; DiGiovanna JJ; Moshell AN; Tarone RE; Peck GL
    N Engl J Med; 1988 Jun; 318(25):1633-7. PubMed ID: 3287161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with low-dose isotretinoin for prevention of basal cell carcinoma: a multicenter clinical trial. Isotretinoin-Basal Cell Carcinoma Study Group.
    Tangrea JA; Edwards BK; Taylor PR; Hartman AM; Peck GL; Salasche SJ; Menon PA; Benson PM; Mellette JR; Guill MA
    J Natl Cancer Inst; 1992 Mar; 84(5):328-32. PubMed ID: 1738183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral isotretinoin therapy. Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas.
    Levine N; Miller RC; Meyskens FL
    Arch Dermatol; 1984 Sep; 120(9):1215-7. PubMed ID: 6591861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The results of topical application of 13-cis-retinoic acid on basal cell carcinoma. A correlation of the clinical effect with histopathological examination and serum retinol level.
    Sankowski A; Janik P; Jeziorska M; Swietochowska B; Cieśla W; Małek A; Przybyszewska M
    Neoplasma; 1987; 34(4):485-9. PubMed ID: 3477702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral isotretinoin therapy for familial Muir-Torre syndrome.
    Spielvogel RL; DeVillez RL; Roberts LC
    J Am Acad Dermatol; 1985 Mar; 12(3):475-80. PubMed ID: 3857234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of basal cell carcinoma with 13-cis-retinoic acid.
    Sankowski A; Janik P; Bogacka-Zatorska E
    Neoplasma; 1984; 31(5):615-8. PubMed ID: 6594593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Jul; 28(1):6-37. PubMed ID: 6235105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of keratoacanthomas with oral 13-cis-retinoic acid.
    Haydey RP; Reed ML; Dzubow LM; Shupack JL
    N Engl J Med; 1980 Sep; 303(10):560-2. PubMed ID: 6931285
    [No Abstract]   [Full Text] [Related]  

  • 15. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.
    Tangrea JA; Adrianza E; Helsel WE; Taylor PR; Hartman AM; Peck GL; Edwards BK
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):375-80. PubMed ID: 8348061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isotretinoin-basal cell carcinoma prevention trial. Design, recruitment results, and baseline characteristics of the trial participants. The ISO-BCC Study Group.
    Tangrea J; Edwards B; Hartman A; Taylor P; Peck G; Salasche S; Menon P; Winton G; Mellette R; Guill M
    Control Clin Trials; 1990 Dec; 11(6):433-50. PubMed ID: 1963135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.
    Molin L; Thomsen K; Volden G; Aronsson A; Hammar H; Hellbe L; Wantzin GL; Roupe G
    Acta Derm Venereol; 1987; 67(3):232-6. PubMed ID: 2442936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinoids in dermatology].
    Quevrin F; Achten G
    Rev Med Brux; 1986 Feb; 7(2):85-91. PubMed ID: 3515480
    [No Abstract]   [Full Text] [Related]  

  • 20. Topical tretinoin treatment in basal cell carcinoma.
    Brenner S; Wolf R; Dascalu DI
    J Dermatol Surg Oncol; 1993 Mar; 19(3):264-6. PubMed ID: 8445111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.